drug · small molecule
patient view →ZIRGAN
updated 2mo agoby $BLCO Bausch & Lomb Corp🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 8 investigational indications.
targets
DNA polymerase catalytic subunit
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that